BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 34421849)

  • 1. Hepadnaviral Lymphotropism and Its Relevance to HBV Persistence and Pathogenesis.
    Coffin CS; Mulrooney-Cousins PM; Michalak TI
    Front Microbiol; 2021; 12():695384. PubMed ID: 34421849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occult persistence and lymphotropism of hepadnaviral infection: insights from the woodchuck viral hepatitis model.
    Michalak TI
    Immunol Rev; 2000 Apr; 174():98-111. PubMed ID: 10807510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymptomatic Hepadnaviral Persistence and Its Consequences in the Woodchuck Model of Occult Hepatitis B Virus Infection.
    Mulrooney-Cousins PM; Michalak TI
    J Clin Transl Hepatol; 2015 Sep; 3(3):211-9. PubMed ID: 26623268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial sites of hepadnavirus integration into host genome in human hepatocytes and in the woodchuck model of hepatitis B-associated hepatocellular carcinoma.
    Chauhan R; Churchill ND; Mulrooney-Cousins PM; Michalak TI
    Oncogenesis; 2017 Apr; 6(4):e317. PubMed ID: 28414318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse Virus and Host-Dependent Mechanisms Influence the Systemic and Intrahepatic Immune Responses in the Woodchuck Model of Hepatitis B.
    Michalak TI
    Front Immunol; 2020; 11():853. PubMed ID: 32536912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PreC and C Regions of Woodchuck Hepatitis Virus Facilitate Persistent Expression of Surface Antigen of Chimeric WHV-HBV Virus in the Hydrodynamic Injection BALB/c Mouse Model.
    Wu W; Liu Y; Lin Y; Pan D; Yang D; Lu M; Xu Y
    Viruses; 2017 Feb; 9(2):. PubMed ID: 28230775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the woodchuck animal model for the treatment of hepatitis B virus-induced liver cancer.
    Suresh M; Menne S
    World J Gastrointest Oncol; 2021 Jun; 13(6):509-535. PubMed ID: 34163570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo infectivity and pathogenicity of the lymphoid cell-derived woodchuck hepatitis virus.
    Lew YY; Michalak TI
    J Virol; 2001 Feb; 75(4):1770-82. PubMed ID: 11160675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of the recombinant genomes of woodchuck hepatitis virus in the mouse model.
    Pan D; Lin Y; Wu W; Song J; Zhang E; Wu C; Chen X; Hu K; Yang D; Xu Y; Lu M
    PLoS One; 2015; 10(5):e0125658. PubMed ID: 25942393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Hepatitis B Virus Genetic Variation, Integration, and Lymphotropism in Antiviral Treatment and Oncogenesis.
    Lau KCK; Burak KW; Coffin CS
    Microorganisms; 2020 Sep; 8(10):. PubMed ID: 32987867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.
    Zhang X; Ma Z; Liu H; Liu J; Meng Z; Broering R; Yang D; Schlaak JF; Roggendorf M; Lu M
    J Hepatol; 2012 Sep; 57(3):522-8. PubMed ID: 22617154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection.
    Menne S; Cote PJ
    World J Gastroenterol; 2007 Jan; 13(1):104-24. PubMed ID: 17206759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphotropism of hepatitis B and C viruses: an update and a newcomer.
    Lamelin JP; Zoulim F; Trépo C
    Int J Clin Lab Res; 1995; 25(1):1-6. PubMed ID: 7787205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis.
    Coffin CS; Michalak TI
    J Clin Invest; 1999 Jul; 104(2):203-12. PubMed ID: 10411550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of Antiviral Effect and Innate Immune Response During Treatment of Primary Woodchuck Hepatocytes.
    Murreddu MG; Suresh M; Gudima SO; Menne S
    Methods Mol Biol; 2017; 1540():277-294. PubMed ID: 27975326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus lymphotropism: emerging details and challenges.
    Joshi SS; Coffin CS
    Biotechnol Genet Eng Rev; 2018 Apr; 34(1):139-151. PubMed ID: 29785877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis.
    Chisari FV
    Curr Top Microbiol Immunol; 1996; 206():149-73. PubMed ID: 8608715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing a new animal model for hepadnaviral infection: susceptibility of Chinese Marmota-species to woodchuck hepatitis virus infection.
    Wang BJ; Tian YJ; Meng ZJ; Jiang M; Wei BQ; Tao YQ; Fan W; Li AY; Bao JJ; Li XY; Zhang ZM; Wang ZD; Wang H; Roggendorf M; Lu MJ; Yang DL
    J Gen Virol; 2011 Mar; 92(Pt 3):681-91. PubMed ID: 21084496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans.
    Korba BE; Cote P; Hornbuckle W; Tennant BC; Gerin JL
    Hepatology; 2000 May; 31(5):1165-75. PubMed ID: 10796894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis.
    Michalak TI; Pardoe IU; Coffin CS; Churchill ND; Freake DS; Smith P; Trelegan CL
    Hepatology; 1999 Mar; 29(3):928-38. PubMed ID: 10051500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.